Partner, Schwegman Lundberg Woessner
Janet Embretson is a shareholder at Schwegman, Lundberg & Woessner and a patent attorney with over 18 years of experience in drafting and prosecuting patents related to a wide variety of subject matter including biotechnology, natural polymers, diagnostic and therapeutic methods, plants, nano- and micro-particle based technologies, as well as devices that may be used in combination with chemical and biological therapies. She did her doctoral work in the lab of Nobel Laureate Howard Temin at the University of Wisconsin-Madison, followed by post doctoral work at Tufts University School of Medicine, Harvard School of Public Health and the University of Minnesota. During her final post-doc, Janet attended Hamline University School of Law. She has been a member of AIPLA and AUTM. Throughout her career as a patent attorney, Janet has served University and corporate clients, as well as individual inventors. She continues to be inspired by scientific advances and to embrace the challenge of turning those advances into intellectual property rights, taking into consideration the impact of recent decisions in patent law and the implementation of AIA.